All lenacapavir articles
-
News
Research reveals how lenacapavir pushes HIV capsid to breaking point
Researchers have uncovered the details of how the novel drug lenacapavir works to stop the virus in its tracks. The molecular mechanisms that they uncovered could help to refine and design more effective anti-viral therapies.
-
News
Calibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care